Table 2.

Multivariate analysis of overall survival and relapse free survival of abn(7) patients.

Tables A and B show the multivariate model for analysis of (A) OS (n = 395) and (B) RFS (n = 231) for intensively treated patients of the abn(7) cohort. In the Cox regression analysis, genomic events (gene mutations and cytogenetic aberrations) were taken as variables and potential clinical confounders as covariates. For clinical continuous variables, a separation into two groups was determined by the median value for age (59 years old) and for WBC (white-blood-cell counts, 9/nL). Genomic events were included in the multivariate analysis Cox regression analysis if they were detected in the > 5% of patients and had a univariate P ≤ 0.10 for OS and RFS before adjustments for multiple comparisons. Cytogenetic aberrations like −7 (Monosomy 7), del(7q), other monosomies, and complex karyotype (CK) are retrieved from clinical information. The hazard ratio is given as HR (95% of CI), and P-values are shown